Sheets Smith Wealth Management Has $764,000 Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Sheets Smith Wealth Management boosted its stake in HealthEquity, Inc. (NASDAQ:HQY) by 3.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,965 shares of the company’s stock after purchasing an additional 273 shares during the period. Sheets Smith Wealth Management’s holdings in HealthEquity were worth $764,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Paladin Wealth LLC acquired a new stake in HealthEquity during the 3rd quarter worth about $39,000. UMB Bank n.a. increased its holdings in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after purchasing an additional 164 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in HealthEquity in the second quarter valued at approximately $73,000. GAMMA Investing LLC boosted its stake in HealthEquity by 57.8% during the third quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock worth $77,000 after acquiring an additional 344 shares in the last quarter. Finally, Quarry LP increased its position in HealthEquity by 418.8% in the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after buying an additional 1,089 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on HQY shares. Royal Bank of Canada upped their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Mizuho assumed coverage on HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target on the stock. BTIG Research upped their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Barrington Research boosted their price target on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. Finally, JMP Securities lifted their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $110.71.

HealthEquity Price Performance

HQY stock opened at $104.74 on Wednesday. The stock has a market capitalization of $9.08 billion, a price-to-earnings ratio of 96.09, a PEG ratio of 1.80 and a beta of 0.54. The firm’s 50-day moving average price is $99.04 and its two-hundred day moving average price is $86.92. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $105.82.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the company posted $0.40 EPS. As a group, equities analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insider Activity at HealthEquity

In related news, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Frank Corvino sold 1,039 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the transaction, the director now owns 3,784 shares of the company’s stock, valued at approximately $363,642.40. The trade was a 21.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 34,289 shares of company stock valued at $3,355,718 in the last three months. Company insiders own 2.20% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.